Thursday, June 11, 2026

HomeGeneral NewsCSL injects $2.3b into US for valuable blood plasma

CSL injects $2.3b into US for valuable blood plasma

- Advertisement -


November 19, 2025 03:30 | News

Australia’s largest biotech company plans to expand its US presence with a $US1.5 billion ($A2.3 billion) investment that will allow it to manufacture more therapies derived from blood…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed